Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients.

Status unconfirmed · Phase 1

Conditions studied: Aphasia, Stroke

In brief

The study investigates the possibility that levetiracetam may improve the symptoms of chronic post-stroke aphasia.

Key facts

Study ID

NCT00227461

Run by

Kessler Foundation

People needed

50

Starts

2005-09-01

Expected to finish

2021-12-01

Last updated by the study team

2021-02-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Stroke
• Aphasia
• Can give consent

You may not qualify if…

• Renal failure
• Pregnancy
• Other neurological condition

Where it is running

• Kessler Foundation — West Orange, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.